Select Page

Skin preperation agents for peripheral IV cannulation

Home Forums Infexion Connexion Skin preperation agents for peripheral IV cannulation

 | Click to Receive Email Notifications of Posts
Viewing 5 posts - 1 through 5 (of 5 total)
  • Author
    Posts
  • #70738
    Fiona de Sousa
    Participant

    Author:
    Fiona de Sousa

    Position:

    Organisation:

    State:

    Hi All,

    In December last year NSW Health published a guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients.

    The recommendation for skin preparation states that
    “For PIVCs that are inserted in Day only or Extended Day Only patients > 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required”

    In the guideline appendix 5 it states that
    “For a cannula that is likely to be in for <24hours, skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep for this cohort of patients.
    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70739
    khipsley@optusnet.com.au
    Participant

    Author:
    khipsley@optusnet.com.au

    Position:

    Organisation:

    State:

    Hi Fiona,
    Ambulance NSW uses chlorhex / alcohol swabs prep for all PIVC with the full knowledge that their cannulas should be removed ASAP or within 24 hours. We do this because aseptic insertion in emergency situations can be difficult if not impossible to achieve.
    Regards,
    Kate Hipsley
    Manager Infection Control
    NSW Ambulance

    Sent from my iPhone

    > On 23 Jan 2014, at 9:35 am, Fiona de Sousa wrote:
    >
    > Hi All,
    >
    > In December last year NSW Health published a guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients.
    >
    > The recommendation for skin preparation states that
    > For PIVCs that are inserted in Day only or Extended Day Only patients > 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required
    >
    > In the guideline appendix 5 it states that
    > For a cannula that is likely to be in for
    > Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.
    >
    > We are interested to know what other facilities are using as skin prep for this cohort of patients.
    > Kind regards,
    >
    > Fiona De Sousa
    > Infection Prevention & Control Coordinator
    > Sydney Adventist Hospital
    > Mobile: 0408 468 470
    > Office: (02) 9487 9732
    > Fax: (02) 9472 8053
    > Fiona.Desousa@sah.org.au
    > 185 Fox Valley Road, Wahroonga, NSW, 2076
    >
    >
    > CAUTION: This message may contain both confidential and privileged information intended for the addressee named above.
    > If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    > is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    > Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    > by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    > _____________________________________________________________________
    > This e-mail has been scanned for viruses by Symantec Hosted Services
    > Scanning Services – powered by MessageLabs. For further information
    > visit http://www.messagelabs.com
    > MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
    > The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
    >
    > Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
    >
    > Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au
    >
    > To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.
    >
    > You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70740
    brett.mitchell@avondale.edu.au
    Participant

    Author:
    brett.mitchell@avondale.edu.au

    Position:

    Organisation:

    State:

    Hi Fiona

    Out of interest, the new EPIC guidelines (EPIC3) have been launched in the UK. EPIC guidelines are national evidenced based guidelines for preventing HAI in the NHS in England. Each recommendation has a grading (based on the level of evidence).

    There is a new recommendation (for them) relating to cutaneous antisepsis when inserting a peripheral vascular device – “decontaminate the skin with at the insertion site with a single-use application of 2% chlorhexidine gluconate in 70% isopropyl alcohol (or povidone iodine in alcohol for patients with sensitivity to chlorhexidine) and allow to dry before inserting a peripheral vascular device”.

    The systematic review processes supporting recommendations are detailed at the back of the guidelines.

    The guidelines can be accessed here – http://www.sciencedirect.com/science/article/pii/S0195670113600122

    The guidelines cover a range of IC practices.

    Thanks
    Brett

    Dr Brett Mitchell
    Senior Lecturer, RN, BN, PhD, M.Adv.Prac, CICP, MRCNA
    Faculty of Nursing and Health
    And
    Lifestyle Research Centre, Cooranbong
    [Description: Description: cid:image001.gif@01CC3C9F.F23555B0]

    Excellence in Christian Tertiary Education since 1897
    185 Fox Valley Road, Wahroonga NSW 2076 Australia

    Avondale College Ltd trading as Avondale College of Higher Education
    http://www.avondale.edu.au | http://www.designedforlife.me

    Hi All,

    In December last year NSW Health published a guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients.

    The recommendation for skin preparation states that
    “For PIVCs that are inserted in Day only or Extended Day Only patients > 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required”

    In the guideline appendix 5 it states that
    “For a cannula that is likely to be in for <24hours, skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep for this cohort of patients.
    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com

    Click here to report this email as spam.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70741
    Anonymous
    Inactive

    Author:
    Anonymous

    Position:

    Organisation:

    State:

    Dear Fiona.

    We are using 2 %chlorhexideine 70%V/v Isopropyl alcohol solution for
    this purpose. Longer contact time on skin. The Corporate body recently
    purchased the ANTT program as it is considered best practice at this
    time and skin preparation of choice is that which is described in all
    instances.

    Regards

    Liz Vanderlinde
    Infection Control Officer
    North West Private Hospital

    Brickport Road, Burnie TAS 7320, Australia
    T +61 3 6432 6022 F +61 3 6431 6158
    E Liz.Vanderlinde@healthecare.com.au
    W | facebook
    | twitter

    is intended only for the use of the addressee(s) named above and may
    contain information that is privileged or subject to copyright. If you
    are not the intended recipient of this message you are hereby notified
    that you must not disseminate, copy or take any action based upon it.
    Please delete and destroy the message from your computer. If you
    received this message in error please notify Healthe Care Australia
    immediately.

    Behalf Of Fiona de Sousa

    Hi All,

    In December last year NSW Health published a guideline called Peripheral
    Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult
    Patients.

    The recommendation for skin preparation states that

    “For PIVCs that are inserted in Day only or Extended Day Only patients >
    70% alcohol solutions/swabs should be used (to reduce unnecessary
    exposure to chlorhexidine when residual antimicrobial activity is not
    required”

    In the guideline appendix 5 it states that

    “For a cannula that is likely to be in for <24hours,
    skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all
    PIVC insertions unless the person has a known sensitivity. We are
    currently reviewing this and are inclined to continue with this product
    as we have known of IVC related BSIs occurring when a PIVC has been
    insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep
    for this cohort of patients.

    Kind regards,

    Fiona De Sousa

    Infection Prevention & Control Coordinator

    Sydney Adventist Hospital

    Fiona.Desousa@sah.org.au

    185 Fox Valley Road, Wahroonga, NSW, 2076

    information intended for the addressee named above.
    If you are not the intended recipient you are hereby notified that any
    dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify
    the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual
    sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of
    Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND
    DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is
    discouraged by ACIPC. If you wish to discuss specific reference to
    products or services by brand or commercial names, please do this
    outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives
    – registration and login required.

    Replies to this message will be directed back to the list. To create a
    new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’
    (without the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70758
    Tim Spencer
    Participant

    Author:
    Tim Spencer

    Position:

    Organisation:

    State:

    Hi Fiona,

    Sorry for the delayed reply as I have just returned from the USA.

    CDC 2011 recommend the following;

    Skin Preparation

    Recommendations

    1. Prepare clean skin with an antiseptic (70% alcohol,
    tincture of iodine, an iodophor or chlorhexidine gluconate) before
    peripheral venous catheter insertion [82]. Category IB

    2. Prepare clean skin with a >0.5% chlorhexidine preparation
    with alcohol before central venous catheter and peripheral arterial
    catheter insertion and during dressing changes. If there is a
    contraindication to chlorhexidine, tincture of iodine, an iodophor, or
    70% alcohol can be used as alternatives [82, 83]. Category IA

    3. No comparison has been made between using chlorhexidine
    preparations with alcohol and povidone-iodine in alcohol to prepare
    clean skin. Unresolved issue.

    4. No recommendation can be made for the safety or efficacy
    of chlorhexidine in infants aged
    70% alcohol solutions/swabs should be used (to reduce unnecessary
    exposure to chlorhexidine when residual antimicrobial activity is not
    required”

    In the guideline appendix 5 it states that

    “For a cannula that is likely to be in for <24hours,
    skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all
    PIVC insertions unless the person has a known sensitivity. We are
    currently reviewing this and are inclined to continue with this product
    as we have known of IVC related BSIs occurring when a PIVC has been
    insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep
    for this cohort of patients.

    Kind regards,

    Fiona De Sousa

    Infection Prevention & Control Coordinator

    Sydney Adventist Hospital

    Fiona.Desousa@sah.org.au

    185 Fox Valley Road, Wahroonga, NSW, 2076

    information intended for the addressee named above.
    If you are not the intended recipient you are hereby notified that any
    dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify
    the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual
    sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of
    Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com

    _____________________________________________________________________
    This email has been scanned for the Sydney & South Western Sydney Local
    Health Districts by the MessageLabs Email Security System.
    Sydney & South Western Sydney Local Health Districts regularly monitor
    email and attachments to ensure compliance with the NSW Ministry of
    Health’s Electronic Messaging Policy.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND
    DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is
    discouraged by ACIPC. If you wish to discuss specific reference to
    products or services by brand or commercial names, please do this
    outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives
    – registration and login required.

    Replies to this message will be directed back to the list. To create a
    new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’
    (without the quotes) to listserv@aicalist.org.au

    _____________________________________________________________________
    This email has been scanned for the Sydney & South Western Sydney Local Health Districts by the MessageLabs Email Security System.
    Sydney & South Western Sydney Local Health Districts regularly monitor email and attachments to ensure compliance with the NSW Ministry of Health’s Electronic Messaging Policy.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 5 posts - 1 through 5 (of 5 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.